Skin Cancer after Ruxolitinib or Belumosudil. Reply.
暂无分享，去创建一个
[1] P. Hari,et al. Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program , 2022, Bone Marrow Transplantation.
[2] Stephanie J. Lee,et al. Three FDA-approved therapies for chronic GVHD. , 2022, Blood.
[3] A. Geller,et al. Incidence and Risk Factors for de novo Cutaneous Squamous Cell Carcinoma in a Contemporary Cohort of Long-term Hematopoietic Cell Transplantation Survivors. , 2021, The Journal of investigative dermatology.
[4] M. Aljurf,et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[5] J. Passweg,et al. Late complications after hematopoietic stem cell transplantation , 2009, Expert review of hematology.